https://ir.kanebiotech.com/ https://ir.kanebiotech.com/news-events/press-releases https://ir.kanebiotech.com/news-events/ir-calendar https://ir.kanebiotech.com/news-events/email-alerts https://ir.kanebiotech.com/company-information https://ir.kanebiotech.com/company-information/presentations https://ir.kanebiotech.com/company-information/management-team https://ir.kanebiotech.com/company-information/contacts https://ir.kanebiotech.com/financial-results https://ir.kanebiotech.com/stock-data/tsxv-kne https://ir.kanebiotech.com/sedar https://ir.kanebiotech.com/governance/board-of-directors https://ir.kanebiotech.com/governance/board-committees https://ir.kanebiotech.com/governance/governance-documents https://ir.kanebiotech.com/news-events/press-releases/detail/434/kane-biotech-announces-250000-insider-loan 2026-10-16T17:05:01-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/433/kane-biotech-to-present-clinical-data-and-showcase-revyve-product-line-at-sawc-fall-2026 2026-10-07T07:05:04-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/432/kane-biotech-to-host-commercial-update-webcast-on-september-16 2026-09-09T07:05:01-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/431/kane-biotech-expands-canadian-commercial-reach-with-ontario-medical-supply-inc 2026-09-02T07:05:01-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/430/kane-biotech-announces-second-quarter-2026-financial-results 2026-08-27T17:32:33-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/429/kane-biotechs-revyve-research-presented-at-military-health-system-research-symposium 2026-08-25T07:25:01-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/428/kane-biotech-announces-engagement-of-dna-advisors 2026-08-05T07:25:01-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/427/kane-biotech-announces-results-of-annual-and-special-meeting-of-shareholders 2026-07-02T07:25:01-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/426/kane-biotech-announces-grant-of-stock-options 2026-05-29T17:05:01-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/425/kane-biotech-announces-first-quarter-2026-financial-results 2026-05-28T17:05:01-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/424/kane-biotech-announces-the-oversubscription-and-closing-of-private-placement-offering 2026-05-26T07:25:01-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/423/kane-biotech-presents-data-to-global-wound-care-community-at-wcetnswocc-2026-joint-congress 2026-05-13T07:25:01-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/422/kane-biotech-announces-new-private-placement-offering 2026-05-07T07:25:01-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/421/kane-biotech-announces-fourth-quarter-and-full-year-2025-financial-results 2026-04-23T18:00:01-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/420/kane-biotech-presents-revyve-clinical-data-at-symposium-on-advanced-wound-care-sawc-spring-conference 2026-04-16T07:25:01-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/419/kane-biotech-announces-publication-in-frontiers-in-antibiotics-highlighting-advancements-in-treating-antibiotic-tolerant-biofilms 2026-03-17T07:25:01-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/418/kane-biotech-expands-u-s-commercial-footprint-with-strategic-distribution-partnership 2026-03-10T07:25:01-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/417/kane-biotech-announces-publication-of-revyve-wound-gel-article-in-the-international-wound-journal 2026-02-20T07:25:01-05:00 https://ir.kanebiotech.com/news-events/press-releases/detail/416/kane-biotech-expands-commercial-activities-in-the-united-states 2026-02-19T07:25:01-05:00 https://ir.kanebiotech.com/news-events/press-releases/detail/415/kane-biotech-announces-fda-510k-clearance-for-revyve-antimicrobial-skin-and-wound-cleanser 2026-02-17T07:25:01-05:00 https://ir.kanebiotech.com/news-events/press-releases/detail/414/kane-biotech-restarts-commercial-activities-and-strengthens-north-american-management 2026-02-12T07:25:01-05:00 https://ir.kanebiotech.com/news-events/press-releases/detail/413/kane-biotech-announces-closing-of-private-placement-offering-with-an-insider-of-the-company 2025-12-18T07:25:01-05:00 https://ir.kanebiotech.com/news-events/press-releases/detail/412/kane-biotech-presents-new-data-at-innovations-in-wound-healing-annual-meeting 2025-12-17T07:25:01-05:00 https://ir.kanebiotech.com/news-events/press-releases/detail/411/kane-biotech-receives-health-canada-approval-for-revyve-antimicrobial-wound-gel-spray 2025-12-10T07:25:01-05:00 https://ir.kanebiotech.com/news-events/press-releases/detail/410/kane-biotech-announces-third-quarter-2025-financial-results 2025-11-28T07:46:58-05:00 https://ir.kanebiotech.com/news-events/press-releases/detail/409/kane-biotech-announces-new-private-placement-offering 2025-11-27T07:25:02-05:00 https://ir.kanebiotech.com/news-events/press-releases/detail/408/kane-biotech-presents-revyve-data-at-diabetic-foot-and-southern-region-burn-conferences 2025-11-04T07:25:01-05:00 https://ir.kanebiotech.com/news-events/press-releases/detail/407/kane-biotech-completes-u-s-fda-510k-submission-for-revyve-antimicrobial-wound-cleanser 2025-09-16T17:05:01-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/406/kane-biotech-completes-enrollment-in-u-s-case-series-studies-of-its-revyve-antimicrobial-wound-gel-and-spray 2025-09-10T17:05:01-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/405/kane-biotech-to-present-revyve-clinical-data-at-symposium-on-advanced-wound-care-sawc-fall-conference 2025-09-04T08:00:02-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/404/kane-biotech-announces-second-quarter-2025-financial-results 2025-08-28T17:05:01-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/403/kane-biotech-showcases-revyve-preclinical-and-clinical-case-study-findings-at-north-american-wound-care-conferences 2025-07-30T08:00:10-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/402/kane-biotech-to-present-at-advanced-wound-care-summit-usa 2025-07-14T17:05:01-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/401/kane-biotech-announces-conversion-of-demand-loan-from-insider-into-an-unsecured-convertible-debenture-and-annual-general-meeting-voting-results 2025-06-26T17:05:01-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/400/kane-biotech-provides-further-corporate-update 2025-06-18T17:05:01-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/399/kane-biotech-announces-first-quarter-2025-financial-results 2025-05-29T17:05:01-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/398/kane-biotech-announces-closing-of-private-placement-offering-and-loan-with-insiders-of-the-company 2025-05-05T17:05:01-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/397/kane-biotech-announces-fourth-quarter-and-full-year-2024-financial-results-narrows-strategic-focus-and-makes-leadership-change 2025-04-28T16:05:05-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/396/kane-biotech-announces-new-agreement-with-outside-the-box-capital-inc 2025-04-11T20:00:01-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/395/kane-biotech-secures-irb-approval-to-launch-innovative-dispersinb-acne-trial 2025-03-13T08:30:01-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/394/kane-biotech-announces-canadian-distribution-agreement-with-best-buy-medical-for-revyve-antimicrobial-wound-gel 2025-03-11T08:30:04-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/393/kane-biotech-announces-second-and-final-closing-of-private-placement-offering 2025-02-19T08:30:21-05:00 https://ir.kanebiotech.com/news-events/press-releases/detail/392/kane-to-host-investor-webinar-what-kane-has-in-store-for-2025-including-the-acquisition-of-fb-dermatology 2025-01-21T08:30:04-05:00 https://ir.kanebiotech.com/news-events/press-releases/detail/391/kane-biotech-announces-first-closing-of-private-placement-offering-and-extension-of-private-placement-offering 2025-01-20T08:30:02-05:00 https://ir.kanebiotech.com/news-events/press-releases/detail/390/kane-biotech-announces-3000000-private-placement-offering 2024-12-03T08:30:02-05:00 https://ir.kanebiotech.com/news-events/press-releases/detail/389/kane-biotech-announces-third-quarter-2024-financial-results 2024-11-28T16:15:01-05:00 https://ir.kanebiotech.com/news-events/press-releases/detail/388/kane-biotech-announces-change-in-us-distribution-partner-for-revyveantimicrobial-wound-gel 2024-11-27T08:30:01-05:00 https://ir.kanebiotech.com/news-events/press-releases/detail/387/kane-biotech-to-release-third-quarter-2024-financial-results-on-november-28-2024 2024-11-21T16:30:03-05:00 https://ir.kanebiotech.com/news-events/press-releases/detail/386/kane-biotech-announces-health-canada-approval-of-revyveantimicrobial-wound-gel 2024-11-14T13:10:07-05:00 https://ir.kanebiotech.com/news-events/press-releases/detail/385/kane-biotech-provides-investor-update-following-fb-dermatology-acquisition-announcement 2024-11-14T08:30:02-05:00 https://ir.kanebiotech.com/news-events/press-releases/detail/384/kane-biotech-announces-agreement-to-acquirefb-dermatology 2024-11-12T13:08:52-05:00 https://ir.kanebiotech.com/news-events/press-releases/detail/383/kane-biotech-announces-donation-of-revyve-antimicrobial-wound-gel-to-ukraine 2024-10-23T08:30:01-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/382/kane-biotech-announces-exclusive-distribution-agreement-with-xsonx 2024-10-17T08:30:03-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/381/kane-biotech-to-participate-in-a-multinational-corporate-collaboration-project 2024-10-03T08:30:02-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/380/kane-biotech-announces-attendance-at-upcoming-wound-care-conferences 2024-09-26T08:30:02-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/379/kane-biotech-announces-exercise-of-warrants 2024-09-12T08:30:02-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/378/kane-biotech-announces-second-quarter-2024-financial-results 2024-08-29T16:15:02-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/377/kane-biotech-announces-new-dispersinb-publication-in-pathogens-and-conference-presentations 2024-08-29T08:30:02-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/376/kane-biotech-announces-distribution-agreement-with-qatar-datamation-systems-for-revyveantimicrobial-wound-gel 2024-08-28T08:40:45-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/375/kane-biotech-to-release-second-quarter-2024-financial-results-on-august-29-2024-conference-call-to-follow 2024-08-22T16:30:01-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/374/kane-biotech-announces-distribution-agreement-with-razan-medical-trading-for-revyve-antimicrobial-wound-gel 2024-08-22T08:30:01-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/373/kane-biotech-receives-funding-support-to-expand-the-revyve-antimicrobial-wound-gel-family 2024-08-13T08:30:02-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/372/kane-biotech-receives-fda-approval-to-increase-dosage-allowance-of-its-revyve-antimicrobial-wound-gel 2024-07-23T08:30:03-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/371/kane-biotech-receives-iso-13485-2016-mdsap-quality-certification 2024-07-17T08:30:03-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/370/kane-biotech-announces-issuance-of-restricted-share-units 2024-07-15T08:30:02-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/369/kane-biotech-signs-worldwide-license-agreement-with-omni-bioceutical-innovations-inc 2024-07-11T08:30:02-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/368/kane-biotech-makes-first-commercial-sale-of-revyve-antimicrobial-wound-gel-to-progenacare-global 2024-06-27T08:30:03-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/367/kane-biotech-signs-worldwide-license-agreement-with-montreal-based-i-med-pharma-inc 2024-06-25T08:30:01-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/366/kane-biotech-announces-first-quarter-2024-financial-results 2024-05-23T16:15:03-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/365/kane-biotech-to-release-first-quarter-2024-financial-results-on-may-23-2024 2024-05-16T08:00:02-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/364/kane-biotech-expands-its-wound-care-portfolio-with-patented-schultz-biofilm-wound-map 2024-05-15T08:00:09-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/363/kane-biotech-to-host-investor-webinar 2024-04-16T09:15:01-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/362/kane-biotech-announces-closing-of-the-sale-of-stem-animal-health-to-dechra-veterinary-products 2024-04-15T09:15:01-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/361/kane-biotech-announces-agreement-in-principle-for-the-sale-of-its-interest-in-stem-animal-health 2024-04-11T09:45:01-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/360/kane-biotech-announces-fourth-quarter-and-full-year-2023-financial-results 2024-03-26T16:05:03-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/359/kane-biotech-extends-exclusivity-period-on-its-offer-for-its-interest-in-stem-animal-health 2024-03-20T08:30:02-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/358/kane-biotech-to-release-fourth-quarter-and-full-year-2023-financial-results-on-march-26-2024-conference-call-to-follow 2024-03-19T16:10:01-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/357/kane-biotech-receives-bioscience-association-manitoba-company-of-the-year-award 2024-03-08T09:00:01-05:00 https://ir.kanebiotech.com/news-events/press-releases/detail/356/dr-robert-huizinga-elected-to-the-kane-biotech-board-and-appointed-executive-chair 2024-02-22T08:00:06-05:00 https://ir.kanebiotech.com/news-events/press-releases/detail/355/kane-biotech-files-new-patent-on-revyve-antimicrobial-wound-gel-spray 2024-01-31T08:30:02-05:00 https://ir.kanebiotech.com/news-events/press-releases/detail/354/kane-biotech-to-present-its-revyve-antimicrobial-wound-gel-at-boswick-burn-and-wound-care-symposium 2024-01-25T12:03:39-05:00 https://ir.kanebiotech.com/news-events/press-releases/detail/353/kane-biotech-announces-special-meeting-of-shareholders 2024-01-18T16:30:01-05:00 https://ir.kanebiotech.com/news-events/press-releases/detail/352/kane-biotech-announces-correction-to-press-release 2023-12-29T14:33:41-05:00 https://ir.kanebiotech.com/news-events/press-releases/detail/351/kane-biotech-announces-amendment-to-its-credit-facility 2023-12-28T16:05:01-05:00 https://ir.kanebiotech.com/news-events/press-releases/detail/350/kane-biotech-receives-offer-for-its-interest-in-stem-animal-health 2023-12-20T08:29:01-05:00 https://ir.kanebiotech.com/news-events/press-releases/detail/349/kane-biotech-announces-improved-third-quarter-2023-financial-results 2023-11-28T16:05:05-05:00 https://ir.kanebiotech.com/news-events/press-releases/detail/348/kane-biotech-to-release-third-quarter-2023-financial-results-on-november-28-2023-conference-call-to-follow 2023-11-21T07:45:01-05:00 https://ir.kanebiotech.com/news-events/press-releases/detail/347/kane-biotech-strengthens-board-with-biotech-executive 2023-11-16T13:45:55-05:00 https://ir.kanebiotech.com/news-events/press-releases/detail/346/kane-biotech-and-progenacare-global-launch-newly-rebranded-revyve-antimicrobial-wound-gel-at-advanced-wound-care-fall-forum 2023-11-02T11:48:09-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/345/kane-biotech-to-exhibit-at-symposium-on-advanced-wound-care-fall-forum 2023-10-25T07:45:01-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/344/kane-biotech-announces-closing-of-fully-subscribed-private-placement-offering-and-amendments-to-its-credit-facility 2023-09-12T07:45:01-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/343/kane-biotech-announces-second-quarter-2023-financial-results 2023-10-17T13:37:10-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/342/kane-biotech-to-release-second-quarter-2023-financial-results-on-aug-29-2023-conference-call-to-follow 2023-08-22T07:30:02-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/341/kane-biotech-announces-private-placement-offering-and-proposed-amendments-to-its-credit-facility 2023-08-03T07:45:02-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/340/kane-biotech-engages-research-capital-to-conduct-strategic-review-of-stem-animal-health 2023-08-02T07:30:02-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/339/kane-biotech-announces-issuance-of-restricted-share-units 2023-06-23T17:30:01-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/338/kane-biotech-announces-first-quarter-2023-financial-results 2023-05-25T16:05:01-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/337/kane-biotech-announces-fda-510k-clearance-for-its-coactiv-antimicrobial-wound-gel 2023-05-25T10:38:10-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/336/kane-biotech-to-release-first-quarter-2023-financial-results-on-may-25-2023-conference-call-to-follow 2023-05-18T16:05:07-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/335/kane-biotech-announces-fourth-quarter-and-full-year-2022-financial-results 2023-04-20T16:05:09-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/334/kane-biotech-announces-distribution-agreement-with-progenacare-global-for-its-coactiv-antimicrobial-wound-gel 2023-04-20T07:30:03-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/333/kane-biotech-announces-additional-coactiv-animal-health-licensing-agreement 2023-04-18T07:30:03-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/332/kane-biotech-to-release-fourth-quarter-and-full-year-2022-financial-results-on-april-20-2023-conference-call-to-follow 2023-04-13T16:30:05-04:00 https://ir.kanebiotech.com/news-events/press-releases/detail/331/kane-biotech-clarifies-terms-of-credit-facility 2023-03-03T18:41:26-05:00 https://ir.kanebiotech.com/news-events/press-releases/detail/330/kane-biotech-announces-amendment-to-its-credit-facility 2023-03-02T16:32:04-05:00 https://ir.kanebiotech.com/news-events/press-releases/detail/329/kane-biotech-announces-proposed-amendments-to-its-credit-facility-and-changes-to-its-board-of-directors 2023-03-01T08:53:41-05:00 https://ir.kanebiotech.com/news-events/press-releases/detail/328/kane-biotechs-coactiv-technology-could-address-a-pricey-and-painful-problem-lack-of-healing-in-chronic-wounds-due-to-microbial-biofilm-formation 2023-02-07T01:33:51-05:00 https://ir.kanebiotech.com/news-events/press-releases/detail/327/kane-biotech-announces-extension-of-term-of-credit-facility 2023-02-06T07:31:03-05:00 https://ir.kanebiotech.com/news-events/press-releases/detail/326/kane-biotech-announces-first-distribution-agreement-for-its-coactiv-antimicrobial-hydrogel 2023-01-04T07:30:09-05:00 https://ir.kanebiotech.com/news-events/ir-calendar/detail/20260916-kane-biotech-commercial-update-webcast 2026-10-09T11:20:43-04:00 https://ir.kanebiotech.com/company-information/presentations/detail/5111/corporate-presentation 2026-05-28T00:00:00-04:00 https://ir.kanebiotech.com/company-information/presentations/detail/5185/commercial-update-webcast 2026-09-16T00:00:00-04:00 https://ir.kanebiotech.com/disclaimer https://ir.kanebiotech.com/sitemap